Forced expression of NR4A1 represses AML cell viability via inhibition of AML cell proliferation both in vitro and in vivo, and results in strong suppression of the oncogenic MYC pathway in t(8,21) rearranged human AML cells34. This evidence concerns the gene NR4A1 and acute myeloid leukemia.